Currently, Rockwell Medical Inc [RMTI] is trading at $4.10, up 5.40%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RMTI shares have gain 3.54% over the last week, with a monthly amount glided 12.33%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Rockwell Medical Inc [NASDAQ: RMTI] stock has seen the most recent analyst activity on June 24, 2019, when Piper Jaffray initiated its Overweight rating and assigned the stock a price target of $10. Previously, H.C. Wainwright started tracking the stock with Buy rating on May 13, 2019, and set its price target to $11. On November 08, 2016, downgrade downgraded it’s rating to Underperform. Stifel downgraded its rating to a Hold. Morgan Stanley initiated its recommendation with a Underweight and recommended $7 as its price target on August 13, 2015. Oppenheimer reiterated a Outperform rating for this stock on January 27, 2015, and upped its price target to $26. In a note dated January 07, 2015, Oppenheimer initiated an Outperform rating and provided a target price of $24 on this stock.
This stock has fluctuated between a low of $1.16 and a high of $4.57 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. Rockwell Medical Inc [NASDAQ: RMTI] shares were valued at $4.10 at the most recent close of the market. An investor can expect a potential return of 119.51% based on the average RMTI price forecast.
Analyzing the RMTI fundamentals
Trailing Twelve Months sales for Rockwell Medical Inc [NASDAQ:RMTI] were 94.37M which represents 42.88% growth. Gross Profit Margin for this corporation currently stands at 0.13% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.22 and Total Capital is -0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.47.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.87 points at the first support level, and at 3.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.25, and for the 2nd resistance point, it is at 4.41.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Rockwell Medical Inc [NASDAQ:RMTI] is 2.00. Also, the Quick Ratio is 1.60, while the Cash Ratio stands at 0.8. Considering the valuation of this stock, the price to sales ratio is 1.35, the price to book ratio is 5.41.
Transactions by insiders
Recent insider trading involved Chole Timothy, SVP, Chief Commercial Officer, that happened on Oct 01 ’24 when 1001.0 shares were sold. President and CEO, Strobeck Mark completed a deal on Oct 01 ’24 to sell 2163.0 shares. Meanwhile, Officer Strobeck Mark bought 2163.0 shares on Oct 01 ’24.
